321 related articles for article (PubMed ID: 16536818)
1. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
Ryu HK; Kim KM; Yoo EA; Sim WY; Chung BC
Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
[TBL] [Abstract][Full Text] [Related]
2. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
[TBL] [Abstract][Full Text] [Related]
3. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
Dallob AL; Sadick NS; Unger W; Lipert S; Geissler LA; Gregoire SL; Nguyen HH; Moore EC; Tanaka WK
J Clin Endocrinol Metab; 1994 Sep; 79(3):703-6. PubMed ID: 8077349
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies on level of androgens in hair and plasma with premature male-pattern baldness.
Bang HJ; Yang YJ; Lho DS; Lee WY; Sim WY; Chung BC
J Dermatol Sci; 2004 Feb; 34(1):11-6. PubMed ID: 14757277
[TBL] [Abstract][Full Text] [Related]
5. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
[TBL] [Abstract][Full Text] [Related]
6. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
Roberts JL; Fiedler V; Imperato-McGinley J; Whiting D; Olsen E; Shupack J; Stough D; DeVillez R; Rietschel R; Savin R; Bergfeld W; Swinehart J; Funicella T; Hordinsky M; Lowe N; Katz I; Lucky A; Drake L; Price VH; Weiss D; Whitmore E; Millikan L; Muller S; Gencheff C
J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375
[TBL] [Abstract][Full Text] [Related]
7. Influence of estrogens on the androgen metabolism in different subunits of human hair follicles.
Niiyama S; Happle R; Hoffmann R
Eur J Dermatol; 2001; 11(3):195-8. PubMed ID: 11358723
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
Whiting DA; Olsen EA; Savin R; Halper L; Rodgers A; Wang L; Hustad C; Palmisano J;
Eur J Dermatol; 2003; 13(2):150-60. PubMed ID: 12695131
[TBL] [Abstract][Full Text] [Related]
9. A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.
Gisleskog PO; Hermann D; Hammarlund-Udenaes M; Karlsson MO
Clin Pharmacol Ther; 1998 Dec; 64(6):636-47. PubMed ID: 9871428
[TBL] [Abstract][Full Text] [Related]
10. The concentrations of the endogenous C19-steroids in hyperplastic prostatic tissue and the effect of finasteride treatment.
Hill M; Petrik R; Hampl R; Stárka L
Horm Metab Res; 1996 Oct; 28(10):562-4. PubMed ID: 8934217
[TBL] [Abstract][Full Text] [Related]
11. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
Spinucci G; Pasquali R
Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
[TBL] [Abstract][Full Text] [Related]
12. Regional scalp differences of the androgenic metabolic pattern in subjects affected by male pattern baldness.
Puerto AM; Mallol J
Rev Esp Fisiol; 1990 Sep; 46(3):289-96. PubMed ID: 2091154
[TBL] [Abstract][Full Text] [Related]
13. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
Whiting DA
Eur J Dermatol; 2001; 11(4):332-4. PubMed ID: 11399540
[TBL] [Abstract][Full Text] [Related]
14. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
Kaufman KD; Olsen EA; Whiting D; Savin R; DeVillez R; Bergfeld W; Price VH; Van Neste D; Roberts JL; Hordinsky M; Shapiro J; Binkowitz B; Gormley GJ
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):578-89. PubMed ID: 9777765
[TBL] [Abstract][Full Text] [Related]
15. Androgen responsive genes as they affect hair growth.
Sawaya ME; Keane RW; Blume-Peytavi U; Mullins DL; Nusbaum BP; Whiting D; Nicholson DW
Eur J Dermatol; 2001; 11(4):304-8. PubMed ID: 11399535
[TBL] [Abstract][Full Text] [Related]
16. Effect of finasteride on human testicular steroidogenesis.
Castro-Magana M; Angulo M; Fuentes B; Canas A; Sarrantonio M; Arguello R; Vitollo P
J Androl; 1996; 17(5):516-21. PubMed ID: 8957695
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
Wolff H; Kunte C
MMW Fortschr Med; 1999 Sep; 141(37):38-40. PubMed ID: 10897972
[TBL] [Abstract][Full Text] [Related]
18. Androgens and alopecia.
Kaufman KD
Mol Cell Endocrinol; 2002 Dec; 198(1-2):89-95. PubMed ID: 12573818
[TBL] [Abstract][Full Text] [Related]
19. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
Finasteride Male Pattern Hair Loss Study Group
Eur J Dermatol; 2002; 12(1):38-49. PubMed ID: 11809594
[TBL] [Abstract][Full Text] [Related]
20. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]